Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Non-Hodgkin Lymphoma (Late Stage^), 2014-2018

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Rate
State
 sort alphabetically by name ascending
Met Healthy People Objective of ***?
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate ascending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 *** 12.1 (12.1, 12.2) N/A 45,360 63.4
Wisconsin 6 *** 15.1 (14.7, 15.5) 1 (1, 4) 1,065 71.5
Iowa 3 *** 14.7 (14.1, 15.2) 2 (1, 7) 555 69.1
Maine 6 *** 14.6 (13.8, 15.4) 3 (1, 10) 274 70.6
Minnesota 6 *** 14.3 (13.9, 14.7) 4 (2, 8) 923 67.0
Pennsylvania 6 *** 14.0 (13.8, 14.3) 5 (3, 9) 2,314 67.3
South Dakota 6 *** 13.7 (12.6, 14.8) 6 (1, 32) 139 69.9
West Virginia 6 *** 13.5 (12.9, 14.2) 7 (3, 25) 331 69.6
Kentucky 3 *** 13.5 (13.0, 14.0) 8 (4, 20) 712 68.6
Delaware 6 *** 13.4 (12.5, 14.4) 9 (1, 31) 163 69.3
Nebraska 6 *** 13.3 (12.6, 14.0) 10 (3, 27) 292 66.3
Idaho 3 *** 13.2 (12.4, 13.9) 11 (4, 31) 249 67.6
New Jersey 3 *** 13.1 (12.8, 13.5) 12 (7, 24) 1,391 59.8
New York 3 *** 13.1 (12.9, 13.3) 13 (7, 21) 3,063 61.0
Michigan 5 *** 13.0 (12.7, 13.3) 14 (8, 25) 1,587 66.5
Ohio 6 *** 13.0 (12.8, 13.3) 15 (8, 24) 1,855 67.9
Connecticut 3 *** 13.0 (12.5, 13.5) 16 (6, 28) 585 62.7
New Hampshire 6 *** 13.0 (12.2, 13.8) 17 (4, 34) 225 63.2
Illinois 6 *** 12.9 (12.7, 13.2) 18 (9, 25) 1,896 66.5
North Dakota 6 *** 12.9 (11.8, 14.1) 19 (3, 36) 109 69.4
Vermont 6 *** 12.9 (11.8, 14.1) 20 (3, 36) 107 67.7
Missouri 6 *** 12.8 (12.5, 13.2) 21 (8, 28) 952 69.5
Indiana 6 *** 12.8 (12.4, 13.1) 22 (10, 29) 976 69.2
Kansas 6 *** 12.7 (12.2, 13.3) 23 (8, 33) 426 66.2
Utah 3 *** 12.6 (12.0, 13.2) 24 (8, 34) 331 68.9
Maryland 6 *** 12.5 (12.1, 12.9) 25 (13, 32) 865 70.3
Oregon 6 *** 12.4 (11.9, 12.8) 26 (14, 34) 619 66.1
Louisiana 3 *** 12.3 (11.9, 12.8) 27 (15, 34) 646 65.4
Rhode Island 6 *** 12.2 (11.4, 13.2) 28 (7, 39) 160 62.8
Montana 6 *** 12.2 (11.3, 13.1) 29 (8, 40) 164 66.6
Washington 5 *** 12.1 (11.7, 12.4) 30 (22, 35) 1,000 62.4
Georgia 3 *** 12.0 (11.7, 12.3) 31 (23, 35) 1,300 66.3
North Carolina 6 *** 12.0 (11.7, 12.3) 32 (24, 35) 1,428 68.3
Colorado 6 *** 12.0 (11.6, 12.4) 33 (23, 35) 700 70.3
California 3 *** 12.0 (11.8, 12.1) 34 (26, 35) 5,043 65.7
Oklahoma 6 *** 11.4 (11.0, 11.9) 35 (29, 41) 510 64.3
Florida 6 *** 11.2 (11.0, 11.3) 36 (34, 40) 3,098 47.5
Tennessee 6 *** 11.0 (10.7, 11.4) 37 (34, 42) 876 62.2
Virginia 6 *** 11.0 (10.7, 11.3) 38 (35, 42) 1,055 65.7
Arkansas 6 *** 10.9 (10.5, 11.5) 39 (34, 43) 397 60.8
Mississippi 6 *** 10.9 (10.4, 11.4) 40 (34, 43) 369 64.2
South Carolina 6 *** 10.6 (10.2, 11.0) 41 (36, 43) 640 63.6
Alaska 6 *** 10.3 (9.2, 11.5) 42 (30, 49) 73 62.0
Texas 6 *** 10.1 (9.9, 10.3) 43 (41, 45) 2,747 58.3
Alabama 6 *** 9.7 (9.4, 10.1) 44 (42, 48) 570 61.5
Hawaii 3 *** 9.4 (8.8, 10.1) 45 (42, 49) 167 59.0
District of Columbia 6 *** 9.4 (8.3, 10.5) 46 (38, 50) 62 63.3
Wyoming 6 *** 9.4 (8.3, 10.5) 47 (38, 50) 63 56.2
Arizona 6 *** 9.1 (8.9, 9.4) 48 (44, 49) 762 59.4
Nevada 6 *** 9.1 (8.6, 9.7) 49 (43, 50) 238 59.4
New Mexico 3 *** 8.2 (7.6, 8.7) 50 (48, 50) 206 54.5
Puerto Rico 6 *** 5.2 (4.9, 5.5) N/A 228 36.0
Massachusetts 3 ***
data not available
N/A
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 12/01/2021 8:35 pm.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The 1969-2018 US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Coding is generally based on Surveillance, Epidemiology, and End Results (SEER) summary stage but may include other staging variables if necessary.
*** No Healthy People 2020 Objective for this cancer.
Healthy People 2020 Objectives provided by the Centers for Disease Control and Prevention.

Data not available for this combination of data selections.

1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database (2001-2018) - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2020 submission.
3 Source: SEER November 2020 submission. State Cancer Registry also receives funding from CDC's National Program of Cancer Registries.
5 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database (2001-2018) - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2020 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database (2001-2018) - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2020 submission).

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top